MedTrace Logo

COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device

NCT06079021 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-05-01

No results posted yet for this study

Summary

A Prospective, Single-Center trial, in Patients With Acute on Chronic Liver Failure. Study of Standard Medical Care Plus CytoSorb® Compared to Standard Medical Care Alone in a historical group.

Conditions

  • Acute-On-Chronic Liver Failure
  • Anticoagulant Adverse Reaction
  • Sarcopenia
  • Ultrasonography

Interventions

DEVICE

CytoSorb

Application of CytoSorb treatment for 72 hours in patients with ACLF

Sponsors & Collaborators

  • CytoSorbents Europe GmbH

    collaborator INDUSTRY

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Karolien Dams · University Hospital, Antwerp

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-08
Primary Completion
2027-09-30
Completion
2027-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06079021 on ClinicalTrials.gov